[WEBINAR] Building flow chemistry workstations for fast reaction screening and optimization
[WEBINAR] In this webinar, we share methods to screen and optimize reactions under extreme time constraints using flow chemistry setups integrated with PAT.
Cutting edge process development insights and news from APC.
[WEBINAR] In this webinar, we share methods to screen and optimize reactions under extreme time constraints using flow chemistry setups integrated with PAT.
Predicting the percolation threshold, using statistical models or experimentation, is an evidence-based approach that can get solid dosage forms designed faster.
[WEBINAR] Traditional solvent screening takes too long to fix issues for fast-moving clinical candidates. But modeling & smart experiments speed things up.
Computational methods play an increasingly important role in all stages of drug development and when used judiciously can help accelerate the timelines required to get over various process and manufacturing hurdles.
APC welcomed Irish Prime Minister to discuss fast-tracking a COVID-19 vaccine with Australian firm Vaxine, showcasing our role in advancing vital medicines.
APC’s CEO Dr Mark Barrett, discusses Ireland’s involvement in the pharmaceutical industry and APC’s current plans on developing a COVID-19 vaccine in partnership with Vaxine Pty Ltd.
Irish R&D firm APC partners with Australian biotech Vaxine to speed up COVID-19 vaccine candidate development, accelerating the time to patients.
APC has joined the Advanced Mammalian Biomanufacturing Innovation Center (AMBIC) as one of the 26 industrial partners.
A Message from the APC Team to Collaborators, "Now, more than ever, collaboration is vital."
Collaboration between Takeda and APC will design, optimize and deliver process improvements for Takeda’s portfolio of biologics-based medicines.